242 related articles for article (PubMed ID: 31918267)
1. MicroRNA-9 and breast cancer.
Li X; Zeng Z; Wang J; Wu Y; Chen W; Zheng L; Xi T; Wang A; Lu Y
Biomed Pharmacother; 2020 Feb; 122():109687. PubMed ID: 31918267
[TBL] [Abstract][Full Text] [Related]
2. The Role of Different Types of microRNA in the Pathogenesis of Breast and Prostate Cancer.
Sidorova EA; Zhernov YV; Antsupova MA; Khadzhieva KR; Izmailova AA; Kraskevich DA; Belova EV; Simanovsky AA; Shcherbakov DV; Zabroda NN; Mitrokhin OV
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768298
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
4. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.
Goh JN; Loo SY; Datta A; Siveen KS; Yap WN; Cai W; Shin EM; Wang C; Kim JE; Chan M; Dharmarajan AM; Lee AS; Lobie PE; Yap CT; Kumar AP
Biol Rev Camb Philos Soc; 2016 May; 91(2):409-28. PubMed ID: 25631495
[TBL] [Abstract][Full Text] [Related]
5. Exosomal microRNA: a novel biomarker for breast cancer.
He Y; Deng F; Yang S; Wang D; Chen X; Zhong S; Zhao J; Tang J
Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358
[TBL] [Abstract][Full Text] [Related]
6. The miR-30 family: Versatile players in breast cancer.
Yang SJ; Yang SY; Wang DD; Chen X; Shen HY; Zhang XH; Zhong SL; Tang JH; Zhao JH
Tumour Biol; 2017 Mar; 39(3):1010428317692204. PubMed ID: 28347244
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
8. MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1.
Zhang ZG; Chen WX; Wu YH; Liang HF; Zhang BX
Biochem Biophys Res Commun; 2014 Nov; 454(1):109-14. PubMed ID: 25450365
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.
Liu B; Tian Y; Li F; Zhao Z; Jiang X; Zhai C; Han X; Zhang L
Oncol Rep; 2016 Jun; 35(6):3178-84. PubMed ID: 27109339
[TBL] [Abstract][Full Text] [Related]
10. miR-214 inhibits epithelial-mesenchymal transition of breast cancer cells via downregulation of RNF8.
Min L; Liu C; Kuang J; Wu X; Zhu L
Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):791-798. PubMed ID: 31294443
[TBL] [Abstract][Full Text] [Related]
11. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
12. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
Deng X; Zhao Y; Wang B
Oncol Rep; 2015 Oct; 34(4):2188-94. PubMed ID: 26238950
[TBL] [Abstract][Full Text] [Related]
13. Potential roles of the exosome/microRNA axis in breast cancer.
Mamalo AS; Alivirdiloo V; Sadeghnejad A; Hajiabbasi M; Gargari MK; Valilo M
Pathol Res Pract; 2023 Nov; 251():154845. PubMed ID: 37839359
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.
Zhang G; Zhang W; Li B; Stringer-Reasor E; Chu C; Sun L; Bae S; Chen D; Wei S; Jiao K; Yang WH; Cui R; Liu R; Wang L
Breast Cancer Res; 2017 Jun; 19(1):73. PubMed ID: 28637482
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
Bertoli G; Cava C; Castiglioni I
Theranostics; 2015; 5(10):1122-43. PubMed ID: 26199650
[TBL] [Abstract][Full Text] [Related]
16. Plasma exosome microRNAs are indicative of breast cancer.
Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
[TBL] [Abstract][Full Text] [Related]
17. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
18. Role of miR-10b in breast cancer metastasis.
Ma L
Breast Cancer Res; 2010; 12(5):210. PubMed ID: 21067538
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential.
Wang W; Luo YP
J Zhejiang Univ Sci B; 2015 Jan; 16(1):18-31. PubMed ID: 25559952
[TBL] [Abstract][Full Text] [Related]
20. Regulation of RAB22A by mir-193b inhibits breast cancer growth and metastasis mediated by exosomes.
Sun L; He M; Xu N; Xu DH; Ben-David Y; Yang ZY; Li YJ
Int J Oncol; 2018 Dec; 53(6):2705-2714. PubMed ID: 30272274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]